Article Versions Notes

Imbrici P, Conte E, Blunck R, Stregapede F, Liantonio A, Tosi M, D’Adamo MC, De Luca A, Brankovic V, Zanni G. A Novel KCNA2 Variant in a Patient with Non-Progressive Congenital Ataxia and Epilepsy: Functional Characterization and Sensitivity to 4-Aminopyridine. International Journal of Molecular Sciences. 2021; 22(18):9913. https://doi.org/10.3390/ijms22189913

Imbrici, Paola, Elena Conte, Rikard Blunck, Fabrizia Stregapede, Antonella Liantonio, Michele Tosi, Maria Cristina D’Adamo, Annamaria De Luca, Vesna Brankovic, and Ginevra Zanni. 2021. "A Novel KCNA2 Variant in a Patient with Non-Progressive Congenital Ataxia and Epilepsy: Functional Characterization and Sensitivity to 4-Aminopyridine" International Journal of Molecular Sciences 22, no. 18: 9913. https://doi.org/10.3390/ijms22189913

Imbrici, P., Conte, E., Blunck, R., Stregapede, F., Liantonio, A., Tosi, M., D’Adamo, M. C., De Luca, A., Brankovic, V., & Zanni, G. (2021). A Novel KCNA2 Variant in a Patient with Non-Progressive Congenital Ataxia and Epilepsy: Functional Characterization and Sensitivity to 4-Aminopyridine. International Journal of Molecular Sciences, 22(18), 9913. https://doi.org/10.3390/ijms22189913